The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APPLE INC | COM | 037833100 | 16,406 | 120,000 | SH | SOLE | 0 | 0 | 0 | ||
COCA COLA CO | COM | 191216100 | 3,460 | 55,000 | SH | SOLE | 0 | 0 | 0 | ||
CORNERSTONE STRATEGIC VALUE | COM | 21924B302 | 12,572 | 1,465,275 | SH | SOLE | 0 | 0 | 0 | ||
CORNERSTONE TOTAL RETURN FD | COM | 21924U300 | 11,572 | 1,389,193 | SH | SOLE | 0 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 646 | 3,813 | SH | SOLE | 0 | 0 | 0 | ||
SELECT SECTOR SPDR TR | SBI INT-INDS | 81369Y704 | 407 | 4,665 | SH | SOLE | 0 | 0 | 0 | ||
SUMMIT THERAPEUTICS INC | COM | 86627T108 | 300 | 300,000 | SH | SOLE | 0 | 0 | 0 |